The content on this site is intended for healthcare professionals only
The LRF CLL4 trial: long-term outcomes
Expert panel discussion: The best of iwCLL 2015
Targeting the NEDD8-activating enzyme to induce apoptosis in CLL cells
Genetic deletions in CLL
High remission rates for new CLL treatment
CLL from a patient and physician perspective
The changing landscape of the young investigator meeting at iwCLL 2015
Ethnic variations in CLL prevalence
Risk of bleeding-related adverse events in ibrutinib treated CLL patients
Epidemiology of CLL: Interlymph consortium and genome-wide sequencing studies
Primary results from the MABLE phase IIIb study
Results of subgroup analysis of the HELIOS trial
